Principia Biopharma Inc (PRNB)

NASDAQ
100.05
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    99.95 - 100.37

PRNB Overview

Prev. Close
100.05
Day's Range
99.95-100.37
Revenue
50M
Open
99.99
52 wk Range
81.82-101.89
EPS
-2.4
Volume
0
Market Cap
3.33B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
-
P/E Ratio
-
Beta
-
1-Year Change
19.68%
Shares Outstanding
33,259,922
Next Earnings Date
Aug 06, 2021
What is your sentiment on Principia Biopharma Inc?
or
Market is currently closed. Voting is open during market hours.

Principia Biopharma Inc News

Principia Biopharma Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary

Principia Biopharma Inc Company Profile

Principia Biopharma Inc Company Profile

Employees
124

Principia Biopharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing oral therapies to patients with unmet medical needs in immunology and oncology. It uses its Tailored Covalency platform to design and develop reversible covalent and irreversible covalent, small molecule inhibitors. Its pipeline includes PRN1008, PRN1371 and PRN2246. PRN1008 drug candidate is designed for the treatment of chronic immunological disorders. PRN2246 is an irreversible covalent BTK inhibitor for the treatment of multiple sclerosis (MS), and other central nervous system (CNS) diseases. PRN1008 is also being developed for the treatment of multiple autoimmune diseases, such as pemphigus. PRN1371 is an inhibitor of Fibroblast Growth Factor Receptor (FGFR), designed for the treatment of solid tumors. The Company also focuses on developing oral immunoproteasome inhibitor for the treatment of inflammation and autoimmune disorders.

Read More
  • Acquired.
    1
    • the first company with covid vaccine
      2
      • sanofi to buy for $ 3.36 b
        0
        • Any news?
          0
          • what a great start for PRNB. Seems to be setting up for another run.. good luck
            0
            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.